Talarozole - ≥99%, high purity , CAS No.201410-53-9, Inhibitor of CYP26A1

Item Number
T126654
Grouped product items
SKUSizeAvailabilityPrice Qty
T126654-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$165.90
T126654-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$212.90
T126654-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$474.90
View related series
CYP26A1 Inhibitor

Basic Description

SynonymsTalarozole | 201410-53-9 | Rambazole | R115866 | R-115866 | N-(4-(2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl)phenyl)benzo[d]thiazol-2-amine | 201410-66-4 | (+)-Talarozole | XKD9N5CJ6W | N-[4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl]-1,3-benzothiazol-2-amine | CHEMBL459505 | 2-B
Specifications & PurityMoligand™, ≥99%
Biochemical and Physiological Mechanisms

Description: IC50 Value:N/A Talarozole is a potent and selective inhibitor of cytochrome P450 26-mediated breakdown of endogenous all-trans retinoic acid for the treatment of psoriasis and acne[2]. in vitro: Talarozole treatment increased

Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of CYP26A1

Product Properties

ALogP6

Associated Targets(Human)

CYP26A1 Tchem Cytochrome P450 26A1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP26B1 Tchem Cytochrome P450 26B1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP26A1 Tchem Cytochrome P450 26A1 (308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP26B1 Tchem Cytochrome P450 26B1 (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name N-[4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl]-1,3-benzothiazol-2-amine
INCHI InChI=1S/C21H23N5S/c1-3-15(4-2)20(26-14-22-13-23-26)16-9-11-17(12-10-16)24-21-25-18-7-5-6-8-19(18)27-21/h5-15,20H,3-4H2,1-2H3,(H,24,25)
InChi Key SNFYYXUGUBUECJ-UHFFFAOYSA-N
Canonical SMILES CCC(CC)C(C1=CC=C(C=C1)NC2=NC3=CC=CC=C3S2)N4C=NC=N4
Isomeric SMILES CCC(CC)C(C1=CC=C(C=C1)NC2=NC3=CC=CC=C3S2)N4C=NC=N4
PubChem CID 9799888
Molecular Weight 377.51

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

Solubility25°C: DMSO

Related Documents

References

1. Verfaille CJ, Thissen CA, Bovenschen HJ, Mertens J, Steijlen PM, van de Kerkhof PC.  (2007)  Oral R115866 in the treatment of moderate to severe plaque-type psoriasis..  J Eur Acad Dermatol Venereol,  21  (8): (1038-46).  [PMID:17714122]
2. Verfaille CJ, Coel M, Boersma IH, Mertens J, Borgers M, Roseeuw D.  (2007)  Oral R115866 in the treatment of moderate to severe facial acne vulgaris: an exploratory study..  Br J Dermatol,  157  (1): (122-6).  [PMID:17459036]

Solution Calculators